Pre-diabetes Clinical Trial
— Project NOT MEOfficial title:
Evaluation of Video On-Demand Programming to Prevent Type 2 Diabetes in Adults
Verified date | December 2014 |
Source | UnitedHealth Group |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Over the past 40 years, diabetes has increased dramatically in parallel with rapid increases
in obesity.About 90 to 95% of persons with diabetes have type 2 diabetes, which begins when
the body becomes resistant to the hormone insulin. Insulin resistance results from weight
gain and physical inactivity, making the vast majority of new cases of type 2 diabetes
preventable with lifestyle changes.
After the findings of the Diabetes Prevention Program were released in 2002, the high cost
of the lifestyle program prevented it from becoming widely adopted throughout the U.S.
The UnitedHealth Center for Health Reform and Modernization (CHRM) will evaluate the use and
effectiveness of a scalable approach for providing lifestyle-based diabetes prevention
intervention through Comcast's XFINITY Video-On-Demand (VOD) programming, with additional
non-compulsory support from SparkPeopleTM (Cincinnati, Ohio), an interactive tracking and
problem solving web portal. By design, this effort will engage adult television viewers and
offer them education and resources to support their efforts to achieve levels of weight loss
and physical activity which have previously shown to prevent the development of type 2
diabetes. Specifically, we aim to evaluate:
1. Viewing patterns and characteristics of consumers accessing a prevention program via
VOD
2. Effectiveness in terms of weight loss achieved
3. Consumers' ratings of overall content
Status | Completed |
Enrollment | 306 |
Est. completion date | September 2014 |
Est. primary completion date | May 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Told by a doctor, nurse, or other healthcare provider that he/she has prediabetes or is at very high risk for developing type 2 diabetes - Told by a doctor, nurse or other healthcare provider that he/she has high blood pressure or is receiving prescription medication to treat high blood pressure - Told by a doctor, nurse or other healthcare provider that he/she has abnormal blood cholesterol or is receiving prescription medication to treat blood cholesterol - Has a first-degree blood relative (mother, father, brother or sister) who has or had type 2 diabetes - Is a woman with a personal history of gestational diabetes (diabetes of pregnancy only) Exclusion Criteria: - Currently reports a body weight of more than 310 pounds - Considering bariatric surgery ("stomach stapling" or gastric bypass) in the next 6 months - Told by a doctor or nurse that they have diabetes (except diabetes of pregnancy alone) or is receiving any form of treatment for diabetes - Has poorly controlled high blood pressure, typically more than 180/105, that has not been discussed with a healthcare provider - Is a woman who is currently pregnant or actively planning pregnancy in the next 6 months - Has chest pain, dizziness, or severe shortness of breath or bodily weakness with even moderate levels of physical exertion such as brisk walking - Has been told by a doctor or nurse not to increase his/her current level of physical activity or not to attempt weight loss - Has any other condition, such as advanced heart or lung disease, severe painful arthritis, or another disability that significantly limits physical activities such as brisk walking - Has any other condition, such as malnutrition or unexplained weight loss in which attempts to lose additional body weight could be unsafe |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
UnitedHealth Group | Comcast Corporation, Dr. Ron Ackermann |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline Weight Measure at Week 16 | Weight measures will be taken on electronic scales that transmit the weight using GSM/cellular technology at the start of the study, after each weekly episode, at the end of the evaluation period (week 16) and after all maintenance materials have been delivered (month 12). Self-reported weight will also be collected in the pre-study survey, follow-up survey and through SparkPeople.com. | Baseline - Week 16 | No |
Secondary | Viewing patterns and characteristics of consumers accessing a prevention program via VOD | The following viewing data will be captured by Comcast and made available to the evaluation team with permission from the study participant: date and title for each episode viewed (date / time stamp for episode initiation, total viewing time, confirmation whether episode was viewed in its entirety or viewed more than once). | Week 16 | No |
Secondary | Consumers' ratings of overall content | A survey will be be administered at week 16 containing health related and work productivty questions, the perceived usefulness of the content,intent to make changes in behavior and likelihood to recommend the program to others. | Week 16 | No |
Secondary | Change from Baseline Weight Measure at Month 12 | Weight measures will be taken on electronic scales that transmit the weight using GSM/cellular technology at the start of the study, after each weekly episode, at the end of the evaluation period (week 16) and after all maintenance materials have been delivered (month 12). Self-reported weight will also be collected in the pre-study survey, follow-up survey and through SparkPeople.com. | Baseline and Month 12 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Enrolling by invitation |
NCT05367024 -
Broccoli Effect on Glycated Haemoglobin (HbA1c)
|
N/A | |
Completed |
NCT02933424 -
Project Plant Protein: the P3 Study in Humans
|
N/A | |
Withdrawn |
NCT02400450 -
Designer Functional Foods on Parameters of Metabolic and Vascular in Prediabetes
|
N/A | |
Completed |
NCT02656212 -
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)
|
Phase 1 | |
Completed |
NCT02330276 -
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin
|
Phase 1 | |
Completed |
NCT01488279 -
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
|
N/A | |
Completed |
NCT00831129 -
A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs
|
Phase 2/Phase 3 | |
Completed |
NCT00536250 -
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
|
N/A | |
Recruiting |
NCT05563090 -
Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
|
||
Active, not recruiting |
NCT04991142 -
Models of Nutrition From Continuous Glucose Monitors
|
||
Completed |
NCT02759055 -
Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard)
|
N/A | |
Completed |
NCT00775684 -
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
|
N/A | |
Completed |
NCT03695913 -
Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes
|
N/A | |
Completed |
NCT04051008 -
CTSI Pilot: Improving Adherence to Diabetic Diet
|
N/A | |
Recruiting |
NCT04897945 -
A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus
|
N/A | |
Not yet recruiting |
NCT04442451 -
Mechanisms of Fatigability With Diabetes
|
N/A | |
Not yet recruiting |
NCT05925933 -
High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes
|
N/A | |
Active, not recruiting |
NCT05654051 -
The SLIM LIVER Study
|
Phase 2 | |
Completed |
NCT02919397 -
Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes
|
N/A |